期刊论文详细信息
JOURNAL OF CONTROLLED RELEASE 卷:235
Delivery of LLKKK18 loaded into self-assembling hyaluronic acid nanogel for tuberculosis treatment
Article
Silva, Joao P.1  Goncalves, Carine2,3  Costa, Cesar1  Sousa, Jeremy2,3  Silva-Gomes, Rita2,3  Castro, Antonio G.2,3  Pedrosa, Jorge2,3  Appelberg, Rui4  Miguel Gama, F.1 
[1] Univ Minho, CEB Ctr Biol Engn, Campus Gualtar, P-4710057 Braga, Portugal
[2] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal
[3] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal
[4] Univ Porto, Dept Immunophysiol, P-4050313 Oporto, Portugal
关键词: Antimicrobial peptide;    Macrophages;    Infectious diseases;    Cathelicidin;    Mycobacteria;   
DOI  :  10.1016/j.jconrel.2016.05.064
来源: Elsevier
PDF
【 摘 要 】

Tuberculosis ( TB), a disease caused by the human pathogen Mycobacterium tuberculosis, recently joined HIV/AIDS on the top rank of deadliest infectious diseases. Low patient compliance due to the expensive, long-lasting and multi-drug standard therapies often results in treatment failure and emergence of multi-drug resistant strains. In this scope, antimicrobial peptides (AMPs) arise as promising candidates for TB treatment. Here we describe the ability of the exogenous AMP LLKKK18 to efficiently killmycobacteria. The peptide's potential was boosted by loading into self-assembling Hyaluronic Acid (HA) nanogels. These provide increased stability, reduced cytotoxicity and degradability, while potentiating peptide targeting to main sites of infection. The nanogels were effectively internalized by macrophages and the peptide presence and co-localization with mycobacteria within host cells was confirmed. This resulted in a significant reduction of the mycobacterial load in macrophages infected in vitro with the opportunistic M. avium or the pathogenic M. tuberculosis, an effect accompanied by lowered pro-inflammatory cytokine levels (IL-6 and TNF-alpha). Remarkably, intra-tracheal administration of peptide-loaded nanogels significantly reduced infection levels in mice infected with M. avium or M. tuberculosis, after just 5 or 10 every other day administrations. Considering the reported low probability of resistance acquisition, these findings suggest a great potential of LLKKK18-loaded nanogels for TB therapeutics. (C) 2016 Elsevier B.V. All rights reserved.

【 授权许可】

Free   

【 预 览 】
附件列表
Files Size Format View
10_1016_j_jconrel_2016_05_064.pdf 1560KB PDF download
  文献评价指标  
  下载次数:12次 浏览次数:1次